Literature DB >> 31223434

Potential of ROCK Inhibitors as Treatment for Cardiovascular Diseases, Cancer, and More.

Ahmed F Abdel-Magid1.   

Abstract

Entities:  

Year:  2019        PMID： 31223434      PMCID： PMC6580533          DOI： 10.1021/acsmedchemlett.9b00214

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  4 in total

Review 1.  Rho Kinase (ROCK) Inhibitors and Their Therapeutic Potential.

Authors:  Yangbo Feng; Philip V LoGrasso; Olivier Defert; Rongshi Li
Journal:  J Med Chem       Date:  2015-10-30       Impact factor: 7.446

Review 2.  Rho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.

Authors:  Jianjian Shi; Lei Wei
Journal:  J Cardiovasc Pharmacol       Date:  2013-10       Impact factor: 3.105

Review 3.  ROCK in CNS: Different Roles of Isoforms and Therapeutic Target for Neurodegenerative Disorders.

Authors:  Cheong-Meng Chong; Nana Ai; Simon Ming-Yuen Lee
Journal:  Curr Drug Targets       Date:  2017       Impact factor: 3.465

Review 4.  ROCK as a therapeutic target for ischemic stroke.

Authors:  Nikola Sladojevic; Brian Yu; James K Liao
Journal:  Expert Rev Neurother       Date:  2017-10-30       Impact factor: 4.618
  4 in total
  1 in total

1.  The Design, Synthesis and Evaluation of Rho-kinase Inhibitory Activity of 4-aryl-thiazole-2-amines.

Authors:  Linan Wang; Ben Ouyang; Meixia Fan; Junhui Qi; Lei Yao
Journal:  Iran J Pharm Res       Date:  2021       Impact factor: 1.696
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.